Gelecek Varlık Yönetimi A.Ş. (“Gelecek Varlık”), a leading asset management company operating under Fiba Group, and Anatolia Tanı ve Biyoteknoloji Ürünleri Sanayi ve Ticaret A.Ş. (“Anatolia”), a leading company in molecular diagnosis industry, successfully completed their initial public offerings (“IPO”) and were listed on Borsa Istanbul on the same day, 21 October 2021.
The IPO of Anatolia reached a size of TRY 516,9 million and the IPO of Gelecek Varlık reached a size of TRY 360,4 million and the both IPOs were oversubscribed and attracted a very strong demand by investors. Anatolia with the ticker of “ANGEN” and Gelecek Varlık, with the ticker of “GLCVY”, are trading on Borsa İstanbul as of 21 October 2021. For the first time in Borsa İstanbul’s history, a joint bell-ringing ceremony was held for two companies.
Paksoy is pleased to announce that the deal teams led by partners Omer Collak and Sera Somay together with counsel Ökkeş Şahan, senior associates Soner Dağlı and Merve Kurdak, and associate Bülent Öztürk acted as transaction counsel in these IPOs.
Share
Related persons
You can contact us for detailed information.





Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
19 January 2026
Paksoy advises Amphenol on its acquisition of CommScope’s CCS business
Paksoy advises Amphenol Corporation on its acquisition of CommScope’s Connectivity and Cable Solutions (CCS) business.
14 January 2026
Paksoy advised Stellantis Group on the sale of BPF Pazarlama to TOFAŞ
Paksoy advised Stellantis Group on the sale of BPF Pazarlama to TOFAŞ.
13 January 2026
Paksoy advised IFC on its investment in Getmobil
Paksoy advised IFC on its investment in Getmobil.
12 January 2026
Mergermarket has ranked us #1 Legal Adviser in Turkey by deal value for 2025
Mergermarket has ranked us #1 Legal Adviser in Turkey by deal value for 2025, advising on USD 4.97 billion across 18 transactions.
7 January 2026
Paksoy advises Sanofi on the sale of a majority stake in its Lüleburgaz manufacturing facility
Paksoy advises Sanofi on the sale of a majority stake in its Lüleburgaz manufacturing facility.
5 January 2026
We are pleased to announce the promotion of Sabri Kaya to Counsel, effective as of 1 January 2026
We extend our congratulations to Sabri Kaya on his well-deserved promotion to Counsel.